Online Only Articles

EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia

Department of Human Health Sciences, Kyoto University, Japan
Department of Human Health Sciences, Kyoto University, Japan
Department of Pediatrics, Tokyo Medical and Dental University (TMDU), Japan
Department of Nutritional Science, Aichi Gakuin University, Nisshin, Japan
Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan
Epidemiology and Clinical Research Center for Children’s Cancer, National Center for Child Health and Development, Tokyo, Japan
Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan
Department of Human Health Sciences, Kyoto University, Japan
Department of Pediatrics, Kyoto University, Japan
Department of Human Health Sciences, Kyoto University, Japan
Department of Pediatrics, National Hospital Organization Fukuoka-Higashi Medical Center, Koga, Japan
Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan
Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
Department of Pediatrics, National Hospital Organization Osaka National Hospital, Japan
Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Japan
Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
Department of Hematology and Oncology, Gunma Children’s Medical Center, Shibukawa, Japan
Department of Hematology and Oncology, Gunma Children’s Medical Center, Shibukawa, Japan
Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Japan
Department of Pediatrics, Okayama University Hospitaland, Japan
Department of Pharmacoepidemiology, Kyoto University, Japan
Department of Human Health Sciences, Kyoto University, Japan
Vol. 99 No. 11 (2014): November, 2014 https://doi.org/10.3324/haematol.2014.107128